Arena, Orexigen in spotlight; drug indexes dip

Rivals Orexigen Therapeutics and Arena Pharmaceuticals are in the spotlight as a Food and Drug Administration advisory panel convenes to consider whether to recommend Arena’s diet-drug lorcaserin for approval.